The director of the National Institute of Allergy and Infectious Diseases and the face of the U.S. pandemic response, Dr. Fauci had mild symptoms after testing positive Wednesday.
Tag: National Institute of Allergy and Infectious Diseases
Is the Coronavirus Getting Better at Airborne Transmission?
The Alpha variant traveled more efficiently in small droplets, two new studies found. The Delta variant may have continued this evolution.
U.S. Health Officials Question AstraZeneca Vaccine Trial Results
According to federal officials, an independent panel of medical experts said the promising results announced by the company on Monday may have relied on “outdated information.”
Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective
Moderna is the second company to report preliminary results from a large trial testing a vaccine. But there are still months to go before it will be widely available to the public.
Moderna Coronavirus Vaccine Test in Monkeys Shows Promise
This coronavirus vaccine developed by government researchers and Moderna enabled the animals to quickly clear the infection from their lungs.
Moderna and Pfizer Begin Late-Stage Coronavirus Vaccine Trials
The studies each aim to enroll 30,000 people and determine whether the vaccines are safe and effective.
Remdesivir Coronavirus Trial: Federal Scientists Finally Publish Data
A clinical trial led to the authorization of the only drug shown to work in Covid-19 patients. But until now, few experts had seen the numbers.
How Remdesivir, New Hope for Covid-19 Patients, Was Resurrected
The drug failed as a treatment for hepatitis and Ebola. With federal funding, scientists trained it on the coronavirus.
Remdesivir Shows Modest Benefits in Coronavirus Trial
Hope soared nonetheless. The F.D.A. is likely to issue an emergency approval, a senior official said.
Trial of Coronavirus Vaccine Made by Moderna Begins in Seattle
Healthy volunteers will test different doses of the first vaccine to find out if it is safe.